Results 21 to 30 of about 115,882 (349)
Frequency and Severity of Myasthenia Gravis Exacerbations Associated With the Use of Ciprofloxacin, Levofloxacin, and Azithromycin [PDF]
Muscle &Nerve, Volume 71, Issue 6, Page 1063-1071, June 2025.ABSTRACT Introduction/Aims The true frequency and severity of myasthenia gravis (MG) exacerbation associated with the usage of fluoroquinolone and macrolide antibiotics remain unknown. We aimed to investigate the association between ciprofloxacin, levofloxacin, azithromycin, and MG exacerbation.
Sanem Pinar Uysal +3 more
wiley +2 more sources
Current Treatment of Myasthenia Gravis
Journal of Clinical Medicine, 2022 Myasthenia gravis (MG) is the most extensively studied antibody-mediated disease in humans. Substantial progress has been made in the treatment of MG in the last century, resulting in a change of its natural course from a disease with poor prognosis with
Mohammed K Alhaidar +3 more
semanticscholar +1 more source
Neurological Therapeutics, 2022 We investigated the safety and explore potential efficacy of batoclimab administered subcutaneously in Chinese patients with generalized myasthenia gravis (gMG).
Chong Yan +16 more
semanticscholar +1 more source
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
Annals of Clinical and Translational Neurology, 2022 To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment.
Elena Cortés‐Vicente +24 more
semanticscholar +1 more source
Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with Myasthenia gravis [PDF]
, 2015 Background: Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients have autoanti-bodies against the muscle nicotinic acetylcholine receptor (AChR), while autoantibodies to muscle-specific tyrosine kinase (MuSK) have been detected in ...
Antonini, Giovanni +11 more
core +9 more sources
Neurology and Therapy, 2023 Introduction Myasthenia gravis (MG) is a devastating acquired autoimmune disease that can seriously affect the patient’s quality of life. It is also a common complication of thymoma.
Hongxia Yang +5 more
doaj +1 more source
Burden of disease in myasthenia gravis: taking the patient’s perspective
Journal of Neurology, 2021 Myasthenia gravis (MG) leads to exertion-dependent muscle weakness, but also psychological and social well-being are limited. We aim to describe the burden of disease in MG including sociodemographic, economical, psychosocial as well as clinical aspects,
S. Lehnerer +9 more
semanticscholar +1 more source
BMC Medicine, 2021 Background Myasthenia gravis (MG) is an acquired immune-mediated disorder of the neuromuscular junction that causes fluctuating skeletal muscle weakness and fatigue. Pediatric MG and adult MG have many different characteristics, and current MG diagnostic
Peng Liu +10 more
doaj +1 more source
The epidemiology of myasthenia gravis
Journal of Medicine and Life, 2021 Neuromuscular junction (NMJ) disorders include several dysfunctions that ultimately lead to muscle weakness. Myasthenia gravis (MG) is the most prevalent NMJ disorder with a highly polymorphic clinical presentation and many different faces.
Ana-Maria Bubuioc +4 more
semanticscholar +1 more source
Journal of Cardiothoracic Surgery, 2020 Background Despite the burgeoning literature describing preoperative and postoperative risks of a myasthenic crisis after thymectomy (MCAT) in patients with myasthenia gravis, substantial differences exist in the risk factors identified by previous ...
Chaoying Liu +4 more
doaj +1 more source